Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-09
N
Nicholas J. Baltz
Nephrology Fellow
Also affiliated: University of Arkansas Medical Center (2018); University of Florida (2020)
3 h-index
5 pubs
17 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Nicholas J. Baltz, affiliated with the University of Arkansas for Medical Sciences, has a research profile indicated by a h-index of 3 and 5 total publications, with 15 citations. His work has involved collaboration with Joseph H. Holthoff, also at the University of Arkansas for Medical Sciences, on one shared publication. Baltz's recent publication in 2025, "The Second Slice Tells the Story: Evolving Cryoglobulinemia in Mesangial Glomerulonephritis," suggests an engagement with nephrology and immunology. The Medical Subject Headings associated with his work include "Animals, Humans, Mice, Hematopoiesis, Leukemia, Cell Line, Leukemia, Myeloid, Phosphorylation, Signal Transduction, Down-Regulation," pointing towards research in cellular and molecular mechanisms, potentially related to hematological malignancies and signal transduction pathways. His activity indicates recent engagement in research.
Metrics
- h-index: 3
- Publications: 5
- Citations: 17
Positions
-
Nephrology Fellow publications 2016–2025University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
The Second Slice Tells the Story: Evolving Cryoglobulinemia in Mesangial Glomerulonephritis (2025)
-
Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model (2020)
-
PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia (2018)
-
The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML (2016)
-
JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency (2016)
Collaboration Network
Top Collaborators
Y. Lucy Liu
Army Medical University
5 shared publications
In database
- PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
- The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML
Yan Yan
Winthrop Rockefeller Foundation (US)
4 shared publications
- PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
- The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML
Peter D. Emanuel
Saint Vincent Health System
4 shared publications
In database
- PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
- The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML
Natalia Colorado
Winthrop Rockefeller Foundation
3 shared publications
In database
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
- The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML
Shelly Lensing
Winthrop Rockefeller Foundation (US)
3 shared publications
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
- The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML
Delli Robinson
Winthrop Rockefeller Foundation
3 shared publications
In database
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
- The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML
Jingliao Zhang
University of Florida (US)
2 shared publications
- PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
Daohong Zhou
University of Florida (US)
2 shared publications
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML
Yuqing Liu
Army Medical University (CN)
2 shared publications
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
Michele Cottler‐Fox
Arkansas Department of Agriculture
1 shared publication
In database
- JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
Jason E. Farrar
Arkansas Children's Hospital
1 shared publication
In database
- JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
Zhifu Xiang
University of Arkansas for Medical Sciences (US)
1 shared publication
- PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia
Priyangi A. Malaviarachchi
University of Arkansas for Medical Sciences
1 shared publication
In database
- PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia
Nitza Vara
Winthrop Rockefeller Foundation (US)
1 shared publication
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
Xin Zhang
University of Florida (US)
1 shared publication
- Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
Similar Researchers
Based on overlapping research topics
Neil Dogra
Hendrix College
Disease Mechanisms Research
Immune Response and Inflammation
Receptor Mechanisms and Signaling
Tracy L. Thurman
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Immune Response and Inflammation
Receptor Mechanisms and Signaling
Thomas J. Kelly
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Immune Response and Inflammation
Receptor Mechanisms and Signaling
Brandy Ree
Arkansas Colleges of Health Education
Disease Mechanisms Research
Immune Response and Inflammation
Receptor Mechanisms and Signaling
Reshly Mary Rajan
Disease Mechanisms Research
Immune Response and Inflammation
Cancer Cells and Metastasis
Tong Mu
University of Arkansas – Fort Smith
Disease Mechanisms Research
Immune Response and Inflammation
Receptor Mechanisms and Signaling